Kim‐Hor Hee

438 total citations
18 papers, 320 citations indexed

About

Kim‐Hor Hee is a scholar working on Pharmacology, Oncology and Pharmacology. According to data from OpenAlex, Kim‐Hor Hee has authored 18 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 6 papers in Oncology and 6 papers in Pharmacology. Recurrent topics in Kim‐Hor Hee's work include Antibiotics Pharmacokinetics and Efficacy (8 papers), Antibiotic Resistance in Bacteria (6 papers) and Drug Transport and Resistance Mechanisms (5 papers). Kim‐Hor Hee is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (8 papers), Antibiotic Resistance in Bacteria (6 papers) and Drug Transport and Resistance Mechanisms (5 papers). Kim‐Hor Hee collaborates with scholars based in Singapore, United States and United Kingdom. Kim‐Hor Hee's co-authors include Lawrence Lee, Kok‐Yong Seng, Lawrence Soon-U Lee, Chiang Shiong Loh, Saye Khoo, Nicholas Chew, Dysoley Lek, Nur Sabrina Sapari, Meera Gurumurthy and Qingshu Lu and has published in prestigious journals such as PLoS ONE, Scientific Reports and The Journal of Infectious Diseases.

In The Last Decade

Kim‐Hor Hee

18 papers receiving 310 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kim‐Hor Hee Singapore 11 138 90 83 77 59 18 320
Jinyao Sun China 14 193 1.4× 160 1.8× 86 1.0× 114 1.5× 127 2.2× 18 478
Elizabeth Migoya United States 13 139 1.0× 235 2.6× 53 0.6× 161 2.1× 27 0.5× 27 561
C. Gallion France 11 201 1.5× 52 0.6× 106 1.3× 61 0.8× 36 0.6× 15 446
Charles R. Bonapace United States 8 153 1.1× 68 0.8× 107 1.3× 64 0.8× 154 2.6× 10 453
Sarah Whalley United Kingdom 13 185 1.3× 234 2.6× 37 0.4× 295 3.8× 123 2.1× 16 507
C Restieri Canada 10 108 0.8× 142 1.6× 40 0.5× 187 2.4× 55 0.9× 11 402
Lionell Mandell Canada 7 233 1.7× 60 0.7× 77 0.9× 114 1.5× 92 1.6× 8 406
B. Kemmerich Germany 14 199 1.4× 58 0.6× 68 0.8× 118 1.5× 125 2.1× 29 513
Erika Watanabe Japan 11 242 1.8× 170 1.9× 36 0.4× 113 1.5× 103 1.7× 29 421
Wichai Santimaleeworagun Thailand 14 151 1.1× 114 1.3× 81 1.0× 119 1.5× 209 3.5× 67 547

Countries citing papers authored by Kim‐Hor Hee

Since Specialization
Citations

This map shows the geographic impact of Kim‐Hor Hee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim‐Hor Hee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim‐Hor Hee more than expected).

Fields of papers citing papers by Kim‐Hor Hee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim‐Hor Hee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim‐Hor Hee. The network helps show where Kim‐Hor Hee may publish in the future.

Co-authorship network of co-authors of Kim‐Hor Hee

This figure shows the co-authorship network connecting the top 25 collaborators of Kim‐Hor Hee. A scholar is included among the top collaborators of Kim‐Hor Hee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim‐Hor Hee. Kim‐Hor Hee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Hee, Kim‐Hor, Tze Peng Lim, Tat Ming Ng, et al.. (2022). Therapeutic drug monitoring of meropenem and piperacillin-tazobactam in the Singapore critically ill population – A prospective, multi-center, observational study (BLAST 1). Journal of Critical Care. 68. 107–113. 17 indexed citations
3.
Tam, Vincent H., Lawrence Lee, Tat Ming Ng, et al.. (2020). Performance of Population Pharmacokinetic Models in Predicting Polymyxin B Exposures. Microorganisms. 8(11). 1814–1814. 6 indexed citations
4.
Lee, Lawrence, Kim‐Hor Hee, & Nicholas I. Paton. (2019). 1578. Rifampicin Reduces Tedizolid Concentrations When Co-Administered in Healthy Volunteers. Open Forum Infectious Diseases. 6(Supplement_2). S576–S576. 1 indexed citations
5.
Naftalin, Claire M., Meera Gurumurthy, Kim‐Hor Hee, et al.. (2018). Adjunctive use of celecoxib with anti-tuberculosis drugs: evaluation in a whole-blood bactericidal activity model. Scientific Reports. 8(1). 13491–13491. 16 indexed citations
6.
Popovici, Jean, Saorin Kim, Dysoley Lek, et al.. (2018). Recrudescence, Reinfection, or Relapse? A More Rigorous Framework to Assess Chloroquine Efficacy forPlasmodium vivaxMalaria. The Journal of Infectious Diseases. 219(2). 315–322. 33 indexed citations
7.
Gurumurthy, Meera, Claire M. Naftalin, Kim‐Hor Hee, et al.. (2017). Activity of faropenem with and without rifampicin against Mycobacterium tuberculosis: evaluation in a whole-blood bactericidal activity trial. Journal of Antimicrobial Chemotherapy. 72(7). 2012–2019. 14 indexed citations
8.
9.
Lee, Lawrence Soon-U, Kok‐Yong Seng, Lingzhi Wang, et al.. (2016). Phenotyping of UGT1A1 Activity Using Raltegravir Predicts Pharmacokinetics and Toxicity of Irinotecan in FOLFIRI. PLoS ONE. 11(1). e0147681–e0147681. 5 indexed citations
10.
Seng, Kok‐Yong, et al.. (2015). Population pharmacokinetics of rifampicin and 25-deacetyl-rifampicin in healthy Asian adults. Journal of Antimicrobial Chemotherapy. 70(12). 3298–3306. 29 indexed citations
11.
12.
Seng, Kok‐Yong, et al.. (2015). Population Pharmacokinetic Analysis of Isoniazid, Acetylisoniazid, and Isonicotinic Acid in Healthy Volunteers. Antimicrobial Agents and Chemotherapy. 59(11). 6791–6799. 38 indexed citations
13.
14.
Zhou, Jian, Zuraidah Sulaiman, Ryan Llorin, et al.. (2014). Pharmacokinetics of ertapenem in outpatients with complicated urinary tract infections. Journal of Antimicrobial Chemotherapy. 69(9). 2517–2521. 19 indexed citations
15.
16.
Seng, Kok‐Yong, Kim‐Hor Hee, Nur Sabrina Sapari, et al.. (2013). CYP3A5*3 and bilirubin predict midazolam population pharmacokinetics in Asian cancer patients. The Journal of Clinical Pharmacology. 54(2). 215–224. 16 indexed citations
17.
Hee, Kim‐Hor, et al.. (2009). In vitro flowering and in vitro pollination: methods that will benefit the orchid industry. Victoria University Research Repository (Victoria University). 3 indexed citations
18.
Hee, Kim‐Hor, et al.. (2007). Early in vitro flowering and seed production in culture in Dendrobium Chao Praya Smile (Orchidaceae). Plant Cell Reports. 26(12). 2055–2062. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinyao Sun Breakdown of academic impact, for papers by Elizabeth Migoya Breakdown of academic impact, for papers by C. Gallion Breakdown of academic impact, for papers by Charles R. Bonapace Breakdown of academic impact, for papers by Sarah Whalley Breakdown of academic impact, for papers by C Restieri Breakdown of academic impact, for papers by Lionell Mandell Breakdown of academic impact, for papers by B. Kemmerich Breakdown of academic impact, for papers by Erika Watanabe Breakdown of academic impact, for papers by Wichai Santimaleeworagun
Rankless by CCL
2026